Astrocytes pp 203-217 | Cite as

Detection of Protein Uptake in In Vitro Cultured Astrocytes Exemplified by the Uptake of the Serine Protease, Tissue Plasminogen Activator

  • Ewa E. BresEmail author
  • Andreas FaissnerEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1938)


Astrocytes are heterogeneous cells of the central nervous system whose uptake of neurotransmitters and neuromodulators can influence synaptic signaling. Any malfunction in this process can lead to serious defects in synaptic transmission found in, for example, neurodegenerative diseases like Alzheimer’s or epilepsy.

Here we describe how to visualize the uptake of an extracellularly located protein by in vitro cultured astrocytes on the example of tissue plasminogen activator, a serine protease tightly involved in long-term potentiation and seizure generation.

Key words

Astrocytes Tissue plasminogen activator Protein uptake Gliotransmitters Neuromodulators LRP1 



We thank the IGSN and the DFG, SPP1757 Fa 159/20-1,2 for providing financial support. We also thank Egor Dzyubenko for valuable discussions and help with establishing the astrocytic cultures and Sandra Lata and David Wegrzyn for performing the “test runs” of the protocol and their valuable feedback.


  1. 1.
    Verkhratsky A, Zorec R, Parpura V (2017) Stratification of astrocytes in healthy and diseased brain. Brain Pathol 27(5):629–644CrossRefGoogle Scholar
  2. 2.
    Fernández-Monreal M, López-Atalaya JP, Benchenane K, Leveille F, Cacquevel M, Plawinski L, MacKenzie ET, Bu G, Buisson A, Vivien D (2004) Is tissue-type plasminogen activator a neuromodulator? Mol Cell Neurosci 25:594–601CrossRefGoogle Scholar
  3. 3.
    Cassé F, Bardou I, Danglot L, Briens A, Montagne A, Parcq J, Alahari A, Galli T, Vivien D, Docagne F (2012) Glutamate controls tPA recycling by astrocytes, which in turn influences glutamatergic signals. J Neurosci 32(15):5186–5199CrossRefGoogle Scholar
  4. 4.
    Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA (2003) Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest 112:1533–1540CrossRefGoogle Scholar
  5. 5.
    Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, Vivien D, Buisson A (2001) The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 7(1):59–64CrossRefGoogle Scholar
  6. 6.
    Tsirka SE, Gualandris A, Amaral DG, Strickland S (1997) Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377(6547):340–344CrossRefGoogle Scholar
  7. 7.
    Louessard M, Lacroix A, Martineau M, Mondielli G, Montagne A, Lesept F, Lambolez B, Cauli B, Mothet JP, Vivien D, Maubert E (2016) Tissue plasminogen activator expression is restricted to subsets of excitatory pyramidal glutamatergic neurons. Mol Neurobiol 53(7):5000–5012CrossRefGoogle Scholar
  8. 8.
    Jeanneret V, Wu F, Merino P, Torre E, Diaz A, Cheng L, Yepes M (2016) Tissue-type plasminogen activator (tPA) modulates the postsynaptic response of cerebral cortical neurons to the presynaptic release of glutamate. Front Mol Neurosci 9:121CrossRefGoogle Scholar
  9. 9.
    Wu F, Torre E, Cuellar-Giraldo D, Cheng L, Yi H, Bichler EK, García PS, Yepes M (2015) Tissue-type plasminogen activator triggers the synaptic vesicle cycle in cerebral cortical neurons. J Cereb Blood Flow Metab 35(12):1966–1976CrossRefGoogle Scholar
  10. 10.
    Parcq J, Bertrand T, Montagne A, Baron AF, Macrez R, Billard JM, Briens A, Hommet Y, Wu J, Yepes M, Lijnen HR, Dutar P, Anglés-Cano E, Vivien D (2012) Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicity. Cell Death Differ 19(12):1983–1991CrossRefGoogle Scholar
  11. 11.
    Bertrand T, Lesept F, Chevilley A, Lenoir S, Aimable M, Briens A, Hommet Y, Bardou I, Parcq J, Vivien D (2015) Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR. Cell Death Dis 6:e1924CrossRefGoogle Scholar
  12. 12.
    Samson AL, Nevin ST, Croucher D, Niego B, Daniel PB, Weiss TW, Moreno E, Monard D, Lawrence DA, Medcalf R (2008) Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function. J Neurochem 107(4):1091–1101PubMedPubMedCentralGoogle Scholar
  13. 13.
    Samson AL, Medcalf RL (2006) Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity. Neuron 50(5):673–678CrossRefGoogle Scholar
  14. 14.
    Gottschling C, Dzyubenko E, Geissler M, Faissner A (2016) The indirect neuron-astrocyte coculture assay: an in vitro set-up for the detailed investigation of neuron-glia interactions. J Vis Exp (117):e54757.
  15. 15.
    Schildge S, Bohrer C, Beck K, Schachtrup C (2013) Isolation and culture of mouse cortical astrocytes. J Vis Exp (71):50079.
  16. 16.
    Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez J-Y, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9(7):676–682CrossRefGoogle Scholar
  17. 17.
    Braganza O, Bedner P, Hüttmann K, von Staden E, Friedman A, Seifert G, Steinhäuser C (2012) Albumin is taken up by hippocampal NG2 cells and astrocytes and decreases gap junction coupling. Epilepsia 53(11):1898–1906CrossRefGoogle Scholar
  18. 18.
    Ivens S, Kaufer D, Flores LP, Bechmann I, Zumsteg D, Tomkins O, Seiffert E, Heinemann U, Friedman A (2007) TGF-β receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130:535–547CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Faculty of Biology and Biotechnology, Department of Cell Morphology and Molecular NeurobiologyRuhr University BochumBochumGermany

Personalised recommendations